Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-11-30
1994-12-27
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 5142358, 5142362, 514326, 514341, 514381, 514397, 540603, 544131, 546210, 546276, 546278, 546118, 548252, 548253, 548254, 5483147, A61K 3144, C07D47104, C07D21178
Patent
active
053766660
ABSTRACT:
Novel heterocycle substituted azocycloalkane benzylimidazoles of Formula (I), which are useful as angiotensin-II antagonists, are disclosed: ##STR1##
REFERENCES:
patent: 5128327 (1992-07-01), Chakravarty et al.
patent: 5210092 (1993-05-01), Oku et al.
Dentz Bernard
Reinert Norbert F.
The Du Pont Merck Pharmaceutical Company
LandOfFree
Angiotension-II receptor blocking, azacycloalkyl or azacycloalke does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotension-II receptor blocking, azacycloalkyl or azacycloalke, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotension-II receptor blocking, azacycloalkyl or azacycloalke will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-919968